Ningxia Tairui Pharmaceutical Co., Ltd

~Ningxia Tairui Pharmaceutical Co., Ltd.(Tairui Pharma below)  is an exportoriented national key hightech enterprise with AAA credit rating,owning a Statelevel Enterprise Technical Center and Engineering  Laboratory, nearly 3,500 employees, area coverage of over 400 hectares and total assets of nearly RMB5 billion.
    Tairui Pharma is mainly engaged in R&D, production and marketing of veterinary APIs and formulations. Leading products include Tylosin (Base/Tartrate/ Phosphate), Tilmicosin(phosphate) and Tiamulin Fumarate. Tairui Pharma is proud to delcare itself as the largest producer of Tylosin in the world. Tairui has been titled as China Famous Brand in 2010. Over 70% of its products have been exported to more than 80 countries and areas worldwide. Since 2011Tairui entered a new area by starting the production of Erythromycin Thiocyanate with 1000mt annual capacity at its current site and 3000mt capacity at its subsidiaryNingxia Taipingyang Biotech Co., Ltd. All facilities can meet the requirements of current GMP guidelines and have been successfully approved by customers from the Netherlands, Germany, Switzerland, Australia, India, etc.
    As a China Top 50 Veterinary Pharmaceutical Enterprise and China Top 10 Veterinary API Enterprise, Tairui has always emphasized on developing and introducing new technologies and products in its NationalGrade R&D Center, stateoftheart facilities and wellequipped laboratory so as to meet the growing and changing demands from customers both at home and abroad.
    Following the motto of "Create social wealth, Serve healthcare industry" and undertaking the responsibility of further developing pharmaceutical industry, Tairui Pharma will always strive to build itself into a worldclass API production base and accomplish the ambitious mission of Guarding life, Sharing health.